CinCor Pharma, Inc. Aktie - Unternehmensdaten & Kurse - US17240Y1091 | goSPATZ

CinCor Pharma, Inc.

Share · US17240Y1091 · CINC (XNAS)

Overview Financial Indicators

No Price

n/a

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
-	-	-	-	0,00 %	0,00 %	81,62 %

Company Profile for CinCor Pharma, Inc. Share

CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of treatments for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial to treat chronic kidney diseases. CinCor Pharma, Inc. has a license agreement with F. Hoffman-La Roche Ltd. and Hoffmann-La Roche Inc. The company was incorporated in 2018 and is headquartered in Boston, Massachusetts.

Company Data

Name CinCor Pharma, Inc.

Company CinCor Pharma, Inc.

Symbol CINC

Website https://www.cincor.com

Primary Exchange

NASDAQ

ISIN US17240Y1091

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Mr. Marc M. P. de Garidel

Market Capitalization 1 Mrd.

Country United States of America

Currency USD

Employees 0,0 T

Address 200 Clarendon Street, 02116 Boston

IPO Date 2022-01-07

Ticker Symbols

Name	Symbol
NASDAQ	CINC

More Shares

Investors who CinCor Pharma, Inc. hold also have the following shares in their portfolio:

DAKTRONICS INC Share

WELLS FARGO FINANCE LLC 4.35% NTS 01/04/25 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025